418 related articles for article (PubMed ID: 27625435)
1. Cardiovascular Disease, Statins, and HIV.
Eckard AR; Meissner EG; Singh I; McComsey GA
J Infect Dis; 2016 Oct; 214 Suppl 2(Suppl 2):S83-92. PubMed ID: 27625435
[TBL] [Abstract][Full Text] [Related]
2. The role of statins in the setting of HIV infection.
Eckard AR; McComsey GA
Curr HIV/AIDS Rep; 2015 Sep; 12(3):305-12. PubMed ID: 26126687
[TBL] [Abstract][Full Text] [Related]
3. Statins in HIV-Infected Patients: Potential Beneficial Effects and Clinical Use.
Bernal E; Marín I; Masiá M; Gutiérrez F
AIDS Rev; 2017; 19(2):59-71. PubMed ID: 28182617
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk and dyslipidemia among persons living with HIV: a review.
Maggi P; Di Biagio A; Rusconi S; Cicalini S; D'Abbraccio M; d'Ettorre G; Martinelli C; Nunnari G; Sighinolfi L; Spagnuolo V; Squillace N
BMC Infect Dis; 2017 Aug; 17(1):551. PubMed ID: 28793863
[TBL] [Abstract][Full Text] [Related]
5. Effects of statins beyond lipid-lowering agents in ART-treated HIV infection.
Mehraj V; Chen J; Routy JP
Front Immunol; 2024; 15():1339338. PubMed ID: 38655259
[TBL] [Abstract][Full Text] [Related]
6. Statins for primary cardiovascular disease prevention among people with HIV: emergent directions.
Fitch KV; Fulda ES; Grinspoon SK
Curr Opin HIV AIDS; 2022 Sep; 17(5):293-300. PubMed ID: 35938463
[TBL] [Abstract][Full Text] [Related]
7. Drug therapies for HIV-related metabolic disorders.
Lamarca K; García Sarasola A; Vidal F; Domingo P
Expert Opin Pharmacother; 2016 Jul; 17(10):1327-38. PubMed ID: 27192322
[TBL] [Abstract][Full Text] [Related]
8. HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial.
Gilbert JM; Fitch KV; Grinspoon SK
Top Antivir Med; 2015; 23(4):146-9. PubMed ID: 26713505
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Review of the Usefulness of Statin Therapy in HIV-Infected Patients.
Feinstein MJ; Achenbach CJ; Stone NJ; Lloyd-Jones DM
Am J Cardiol; 2015 Jun; 115(12):1760-6. PubMed ID: 25907504
[TBL] [Abstract][Full Text] [Related]
10. Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach.
deFilippi C; Toribio M; Wong LP; Sadreyev R; Grundberg I; Fitch KV; Zanni MV; Lo J; Sponseller CA; Sprecher E; Rashidi N; Thompson MA; Cagliero D; Aberg JA; Braun LR; Stanley TL; Lee H; Grinspoon SK
J Infect Dis; 2020 Aug; 222(6):929-939. PubMed ID: 32310273
[TBL] [Abstract][Full Text] [Related]
11. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.
Ahmed MH; Al-Atta A; Hamad MA
Expert Opin Pharmacother; 2012 Sep; 13(13):1901-9. PubMed ID: 22770622
[TBL] [Abstract][Full Text] [Related]
12. Clinical management considerations for dyslipidemia in HIV-infected individuals.
Kirchner JT
Postgrad Med; 2012 Jan; 124(1):31-40. PubMed ID: 22314112
[TBL] [Abstract][Full Text] [Related]
13. Primary Prevention of Cardiovascular Disease for People Living with Human Immunodeficiency Virus.
Fox CB; Butler K; Flynn D
Nurs Clin North Am; 2024 Jun; 59(2):219-233. PubMed ID: 38670691
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of HIV infection in Turkey and importance of cardiovascular disease].
Korten V
Turk Kardiyol Dern Ars; 2017 Mar; 45(2):113-117. PubMed ID: 28424432
[No Abstract] [Full Text] [Related]
15. Management of Lipid Levels and Cardiovascular Disease in HIV-Infected Individuals: Just Give Them a Statin?
Stein JH
Top Antivir Med; 2016 Dec-2017 Jan; 23(5):169-73. PubMed ID: 27398770
[TBL] [Abstract][Full Text] [Related]
16. What happens to cardiovascular system behind the undetectable level of HIV viremia?
d'Ettorre G; Ceccarelli G; Pavone P; Vittozzi P; De Girolamo G; Schietroma I; Serafino S; Giustini N; Vullo V
AIDS Res Ther; 2016; 13():21. PubMed ID: 27127532
[TBL] [Abstract][Full Text] [Related]
17. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease and HIV infection: host, virus, or drugs?
Martínez E; Larrousse M; Gatell JM
Curr Opin Infect Dis; 2009 Feb; 22(1):28-34. PubMed ID: 19532078
[TBL] [Abstract][Full Text] [Related]
19. Ischemic Heart Disease in HIV: An In-depth Look at Cardiovascular Risk.
Raposeiras-Roubín S; Triant V
Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1204-1213. PubMed ID: 27840147
[TBL] [Abstract][Full Text] [Related]
20. Exploring Statins to Decrease HIV-Related Heart Disease Risk.
Mitka M
JAMA; 2015 Aug; 314(7):657-9. PubMed ID: 26222872
[No Abstract] [Full Text] [Related]
[Next] [New Search]
